Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease.

Autor: Popler J; Children's Physician Group-Pulmonology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Vece TJ; Division of Pediatric Pulmonology and Program for Rare and Interstitial Lung Disease, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Liptzin DR; School of Public and Community Health, University of Montana, Missoula, Montana, USA.; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., Gower WA; Division of Pediatric Pulmonology and Program for Rare and Interstitial Lung Disease, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Jazyk: angličtina
Zdroj: Pediatric pulmonology [Pediatr Pulmonol] 2023 Feb; Vol. 58 (2), pp. 374-381. Date of Electronic Publication: 2022 Dec 01.
DOI: 10.1002/ppul.26227
Abstrakt: The field of rare and diffuse pediatric lung disease is experiencing rapid progress as diagnostic and therapeutic options continue to expand. In this annual review, we discuss manuscripts published in Pediatric Pulmonology in 2021 in (1) children's interstitial and diffuse lung disease, (2) congenital airway and lung malformations, and (3) noncystic fibrosis bronchiectasis including primary ciliary dyskinesia. These include case reports, descriptive cohorts, trials of therapies, animal model studies, and review articles. The results are put into the context of other literature in the field. Each furthers the field in important ways, while also highlighting the continued need for further studies.
(© 2022 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: